MDXG - Mimedx Group Inc
IEX Last Trade
6.85
0.160 2.336%
Share volume: 2,194,989
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.69
0.16
2.39%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-28 | 2023-05-02 | 2023-08-01 | 2023-10-30 | 2024-02-28 | 2024-04-30 | 2024-07-31 | |
| Total revenue | 67.689 M | 74.375 M | 71.676 M | 81.257 M | 81.712 M | 86.832 M | 84.709 M | 87.207 M | |
| Cost of revenue | 12.188 M | 14.369 M | 12.419 M | 13.583 M | 14.790 M | 13.842 M | 12.987 M | 14.855 M | |
| Gross profit | 55.501 M | 60.006 M | 59.257 M | 67.674 M | 66.922 M | 72.990 M | 71.722 M | 72.352 M | |
| 8.12% | -1.25% | 14.20% | -1.11% | 9.07% | -1.74% | 0.88% | |||
| Operating expenses | 59.428 M | 55.351 M | 58.775 M | 60.422 M | 55.746 M | 48.846 M | 57.970 M | 58.413 M | |
| Selling general and admin | 53.475 M | 49.951 M | 52.279 M | 51.925 M | 52.571 M | 54.349 M | 55.129 M | 55.401 M | |
| Research and development | 5.953 M | 5.400 M | 6.496 M | 8.497 M | 3.175 M | -5.503 M | 2.841 M | 3.012 M | |
| Total expenses | 71.791 M | 69.901 M | 71.384 M | 74.196 M | 70.726 M | 62.879 M | 71.146 M | 73.458 M | |
| -2.63% | 2.12% | 3.94% | -4.68% | -11.09% | 13.15% | 3.25% | |||
| Operating income | -4.102 M | 4.474 M | 292.000 K | 7.061 M | 10.986 M | 23.953 M | 13.563 M | 13.749 M | |
| Ebit | -4.102 M | 4.474 M | 292.000 K | 7.061 M | 10.986 M | 23.953 M | 13.563 M | 13.749 M | |
| Pretax income | -8.373 M | -386.000 K | -4.932 M | 1.126 M | 9.125 M | 25.314 M | 11.409 M | 23.216 M | |
| -95.39% | 1,177.72% | -122.83% | 710.39% | 177.41% | -54.93% | 103.49% | |||
| Income tax | 53.000 K | 28.000 K | 51.000 K | -74.000 K | 591.000 K | -37.374 M | 2.348 M | 5.595 M | |
| Net income basic | -10.096 M | -2.110 M | -6.667 M | -528.000 K | 6.761 M | 58.662 M | 9.061 M | 17.621 M | |
| 79.10% | -215.97% | 92.08% | 1,380.49% | 767.65% | -84.55% | 94.47% | |||
| Net income | -10.096 M | -2.110 M | -6.667 M | -528.000 K | 6.761 M | 58.662 M | 9.061 M | 17.621 M | |
| 79.10% | -215.97% | 92.08% | 1,380.49% | 767.65% | -84.55% | 94.47% |